Tag: Laboratories

Vertex Pharmaceuticals launched its expanded facility in San Diego

vertex pharmaceuticals
Vertex Pharmaceuticals Incorporated announced the opening of its new expanded foot research facility in Torrey Pines, San Diego, USA.

ACM Global Laboratories acquired ABS Laboratories

Rochester Regional Health has announced that its subsidiary, ACM Global Laboratories, has added to its portfolio with the strategic acquisition of ABS Laboratories which is focused on bioanalytical services.

Cambrex will expand its R&D facility in Italy

Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients, announced that it will expand research and development capabilities at its site in Paullo, Milan, Italy.

PPD and NeoGenomics created a strategic alliance

Pharmaceutical Product Development, LLC (PPD) and NeoGenomics Laboratories are forming a strategic alliance to provide a seamless and fully integrated global pathology and molecular testing solution.

Centogene starts a clinical collaboration with Aldeyra Therapeutics

test tubes
Centogene entered into an agreement with Aldeyra Therapeutics Inc., a biotech company developing next-generation medicines to improve the lives of patients with immune-mediated diseases.

Eurofins Scientific seals an outsourcing deal with Astellas

Eurofins Scientific, a global leader in biopharmaceutical products testing services, announces that it has signed an outsourcing agreement with Astellas to outsource one of its internal testing laboratories.

PHAST becomes a part of Eurofins Scientific

Eurofins Scientific, a global leader in biopharmaceutical product testing services, signed an exclusive agreement to acquire PHAST Gesellschaft für Pharmazeutische Qualitätsstandards mbH.

RxCelerate completed the acquisition of bioanalytical CRO Total Scientific

The out-sourced drug development company, RxCelerate Ltd, completed the acquisition of Cambridge-based specialist bioanalytical contract research organisation, Total Scientific Ltd.

WuXi AppTec launches expanded Laboratory Testing Division in USA

WuXi AppTec, a leading global pharmaceutical and medical device company, announced the opening of its expanded Laboratory Testing Division (LTD) facility in New Jersey.

Mobidiag launched a new diagnostic test for bacterial pathogens detection

Mobidiag, a Finnish-French biotechnology company, announced the launch of Novodiag Bacterial GE+, a molecular diagnostic test for the simultaneous detection of most common enteric pathogens.

Thermo Fisher Scientific introduced its novel biological safety cabinet

The cloud-enabled biological safety cabinet that has been specifically developed to address the need for uncompromised contamination control, seamless workflow connectivity and enhanced ease of use in cell culture laboratories.

PPD expanded its GMP analytical laboratory

PPD Laboratories’ new GMP analytical laboratory supplements the company’s existing biologics capacity and was constructed specifically for the stability and quality control testing of large molecule drug products.

Sechenov University establishes the Institute of Bionic Technology and Engineering

The key objectives of the Institute include the development of artificial organs and bionic prostheses, anticoagulant coatings for implants, as well as tissue engineering, intelligent diagnostics, and organs on chips.

Synexus opened its first research centre in Czech Republic

Synexus, the world’s leading site network for clinical trials, has opened its first dedicated research centre in the Czech Republic capital of Prague.

Nanologica entered a service agreement with Sterling Pharma Solutions

Nanologica, a Swedish materials development company, has entered into a service agreement with global CDMO Sterling Pharma Solutions for the large-scale production of silica particles.

Covance creates a global immunology and immunotoxicology unit

LabCorp, a leading global life sciences company, announced that its Covance Drug Development business has formed a global immunology and immunotoxicology (I&I) unit dedicated to the specific needs of biologic drug development.